Europe
Eurofins Scientific, a world leader in biopharmaceutical testing acquired Amatsigroup SAS to support Eurofins’ extensive drug development platform.
sterna biologicals selected as one of a group of top-tier European biotech companies to present at the European Biotech Investor Day on August 1, 2019 in New York City
Evotec SE announced that the Company has been informed by Bayer about positive Phase IIa results from a study surveying the safety, efficacy and dosage of the compound BAY1817080 in refractory chronic cough.
hematologists and multiple myeloma patients in the UK will have access to Dutch developed diagnostic test MMprofilerTM with SKY92 algorithm through the diagnostic service provided by Everything Genetic Ltd. SkylineDx, the diagnostics company that developed the test, announced its collaboration with the UK based provider of a genetic testing service.
The project, led by researchers at the Wellcome Sanger Institute and Massachusetts General Hospital, builds on the previous six years’ study, and practically doubles the volume of novel data available on the website – making it the largest public dataset of its kind in the world.
Gimv, Sofinnova and Gilde Healthcare announced the sale of biopharmaceutical company Breath Therapeutics.
Net sales increased 10 per cent compared to Q2 2018, corresponding to the net of acquisitions and discontinuing operations.
Delivered 31% increase in revenue, 51% increase in operating profit and 60% increase in net profit year-on-year Delivered 21% increase in revenue, with increases in operating profit and net profit compared to Q1 2019 Increased investment in pipeline to support long-term growth
Biotech and pharma companies bolster their executive leadership and boards of directors with this week’s appointments.
“In the first half of the year, we achieved very strong results, driven by high demand for our new medicines,” stated Severin Schwan, Roche’s chief executive officer.
PRESS RELEASES